ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,178,832 | -17.4% | 232,804 | -6.6% | 0.00% | 0.0% |
| Q2 2023 | $5,060,541 | -2.0% | 249,165 | -12.0% | 0.00% | 0.0% |
| Q1 2023 | $5,164,090 | -8.3% | 283,119 | +4.0% | 0.00% | -50.0% |
| Q4 2022 | $5,630,709 | -19.2% | 272,278 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $6,971,000 | -19.3% | 266,514 | -21.8% | 0.00% | -33.3% |
| Q2 2022 | $8,635,000 | -6.8% | 340,764 | +16.1% | 0.00% | +50.0% |
| Q1 2022 | $9,262,000 | +15.2% | 293,474 | +47.7% | 0.00% | 0.0% |
| Q4 2021 | $8,039,000 | +2.6% | 198,630 | -11.6% | 0.00% | 0.0% |
| Q3 2021 | $7,834,000 | +30.6% | 224,684 | +2.9% | 0.00% | +100.0% |
| Q2 2021 | $5,997,000 | -28.3% | 218,353 | -26.7% | 0.00% | -50.0% |
| Q1 2021 | $8,364,000 | +5.7% | 297,877 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $7,911,000 | +61.3% | 304,758 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $4,906,000 | -32.0% | 286,266 | -1.8% | 0.00% | -33.3% |
| Q2 2020 | $7,211,000 | +81.5% | 291,446 | +1.8% | 0.00% | +50.0% |
| Q1 2020 | $3,974,000 | – | 286,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |